/tags/johnson-johnson Johnson & Johnson en-US WLRN Fri, 06 May 2022 13:40:15 GMT /news/2022-05-05/fda-limits-johnson-johnsons-covid-vaccine-to-some-people-due-to-blood-clot-risk The chance of dying after receiving the Janssen vaccine is about 1:2,000,000. But with multiple COVID-19 vaccines available, the FDA is limiting the use of the J&J vaccine. Fri, 06 May 2022 13:40:15 GMT /news/2022-05-05/fda-limits-johnson-johnsons-covid-vaccine-to-some-people-due-to-blood-clot-risk Dustin Jones /news/npr-breaking-news/2022-04-02/rich-companies-are-using-a-quiet-tactic-to-block-lawsuits-bankruptcy Companies that aren't bankrupt are using controversial maneuvers in U.S. bankruptcy court to block tens of thousands of suits. A woman suing Johnson & Johnson died while her case was in legal limbo. Mon, 04 Apr 2022 17:03:03 GMT /news/npr-breaking-news/2022-04-02/rich-companies-are-using-a-quiet-tactic-to-block-lawsuits-bankruptcy Brian Mann /2022-01-25/pfizer-and-biontech-begin-testing-an-omicron-specific-covid-19-vaccine Though people who are vaccinated and boosted appear to be better protected against omicron, the highly contagious variant has still led to breakthrough cases and a surge in infections worldwide. Tue, 25 Jan 2022 15:45:51 GMT /2022-01-25/pfizer-and-biontech-begin-testing-an-omicron-specific-covid-19-vaccine Joe Hernandez /2021-12-30/new-covid-studies-show-promise-for-the-johnson-johnson-vaccine-booster Two studies that have not yet been peer reviewed indicate increased protection against the infectious omicron variant. Thu, 30 Dec 2021 17:55:18 GMT /2021-12-30/new-covid-studies-show-promise-for-the-johnson-johnson-vaccine-booster Joe Palca, Dana Farrington /2021-12-16/cdc-narrows-use-of-j-j-vaccine-due-to-concerns-about-rare-blood-clots The agency implemented experts' advice because of a rare and sometimes fatal blood-clotting problem known as TTS. More than 16 million people in the U.S. have received a shot of the J&J vaccine. Thu, 16 Dec 2021 21:29:37 GMT /2021-12-16/cdc-narrows-use-of-j-j-vaccine-due-to-concerns-about-rare-blood-clots Vanessa Romo, Scott Hensley /2021-10-21/cdc-backs-the-rollout-of-covid-vaccine-boosters-from-moderna-and-j-j CDC Director Rochelle Walensky also endorsed a mix-and-match approach to boosters that would be flexible for patients and health care providers. Thu, 21 Oct 2021 21:39:32 GMT /2021-10-21/cdc-backs-the-rollout-of-covid-vaccine-boosters-from-moderna-and-j-j Scott Hensley /2021-10-20/the-fda-authorizes-moderna-and-j-j-covid-vaccine-boosters The Food and Drug Administration also gave an OK to boosters that differ from the vaccine originally used to immunize people against COVID-19. A mix-and-match approach could ease the booster rollout. Wed, 20 Oct 2021 21:34:54 GMT /2021-10-20/the-fda-authorizes-moderna-and-j-j-covid-vaccine-boosters Scott Hensley /2021-10-15/an-fda-panel-of-experts-backs-j-j-covid-vaccine-booster A panel of experts voted to recommend that the Food and Drug Administration authorize a booster dose of the Johnson & Johnson COVID vaccine at least two months after the first shot. Fri, 15 Oct 2021 17:52:23 GMT /2021-10-15/an-fda-panel-of-experts-backs-j-j-covid-vaccine-booster Scott Hensley /news/2021-10-13/fda-analysis-of-j-j-covid-vaccine-booster-sets-the-stage-for-public-hearing Johnson & Johnson has asked the Food and Drug Administration to authorize a booster for people 18 and older six months after initial immunization, with an option to vaccinate after two months. Wed, 13 Oct 2021 20:17:23 GMT /news/2021-10-13/fda-analysis-of-j-j-covid-vaccine-booster-sets-the-stage-for-public-hearing Scott Hensley /news/2021-10-12/moderna-and-j-j-say-their-data-supports-covid-vaccine-boosters The Food and Drug Administration released briefing documents Tuesday on booster shots for the Moderna and Johnson & Johnson COVID vaccines ahead of a two-day advisory meeting that starts Thursday. Tue, 12 Oct 2021 14:49:46 GMT /news/2021-10-12/moderna-and-j-j-say-their-data-supports-covid-vaccine-boosters Scott Hensley